Key facts
- Delox’s last known valuation is $4.7M (May 2022).
- It has raised $3.8M; the latest was Later Stage VC ($1.9M) in Feb 2026.
- Notable investors include European Innovation Council, European Union, Unicorn Factory Lisboa, European Space Agency, European Investment Bank — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Delox
- ·The full record, as it builds
Funding rounds
No funding rounds for Delox are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Delox
Developer of a decontamination device designed for disinfection purposes. The company's devices like blower kit, catalyser and sensors utilize a proprietary solid hydrogen peroxide formulation to allow faster aeration and effective bio-decontamination, enabling healthcare facilities and laboratories to maintain sterile conditions efficiently.
- Sector
- Healthcare
- HQ
- Lisbon, Portugal
- Founded
- 2018
- Employees
- 10
- Website
- delox-global.com/
- Ownership
- Privately Held (backing)
Delox doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Delox shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Delox in its N-PORT filings yet. We sweep new filings monthly.